Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2010-03-01
Original SEC Filing: Click here

---

Webplus: BSPM/20100301/8-K_1/2_EX-99.1/000.htm SEC Original: ex99-1.htm
Biostar Pharmaceuticals, Inc. Announces 2010 Guidance: Revenues of $69 to $71 million and Net Income $16.2 to $17 million XIANYANG, China, March 1, 2010 (Xinhua-PRNewswire-FirstCall) Biostar forecasts revenues of $69.0 to $71.0 million with net income of $16.2 million to $17 million, excluding any non-cash charges. Management anticipates sales of its flagship product, Xin Aoxing, will represent approximately 68% to

---

---

Webplus: BSPM/20100301/8-K_1/1/000.htm SEC Original: biostar-8k030110.htm
FORM 8-K CURRENT REPORT Date of report (Date of earliest event reported): March 1, 2010 BIOSTAR PHARMACEUTICALS, INC. Maryland 333-147363 20-5101287 (State or other jurisdiction of incorporation or organization) (Commission File No.) (IRS Employer Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province People’s Republic of China 712046 86-029-33686638 (Issuer Telephone Number) N/A (Former name or former address, if

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2010-03-01CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046